EVGN logo

Evogene Ltd. (EVGN)

Profile

Full Name

Evogene Ltd.

Ticker

NASDAQ: EVGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Israel

IPO

October 15, 2010

Indexes

Not included

Website

https://www.evogene.com

Employees

117

Key Details

Price

$1.10(17.07%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$8.51M(50.90% YoY)

Annual EPS

-$2.89(44.64% YoY)

PE Ratio

-

Next earnings date

Mar 5, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.10
    EVGN price is $1.10

    30-Day Relative Volume

    3.12
    EVGN 30-day relative volume is 3.12

    Price Performance

    Price 1-Day Change

    +17.07%
    EVGN price is up +17.07% today

    Price YTD Change

    -41.18%
    EVGN price is down -41.18% since January 1st

    Price 1-Year Change

    -41.18%
    EVGN price is down -41.18% year-on-year

    Price 3-Year Change

    -84.29%
    EVGN price is down -84.29% over the past 3 years

    Price Range

    Price All-Time High

    $203.90
    EVGN price is currently -99.46% below its historical high of $203.90

    Price 3-Year Low

    $0.93
    EVGN price is currently +18.28% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $9.59M
    EVGN market cap is $9.59 million

    Market Cap 3-Year Change

    -66.8%
    EVGN market cap is down -66.8% over the past 3 years

    Market Cap All-Time High

    $495.78M
    EVGN market cap is currently -98.07% below its historical high of $495.78 million

    Market Cap Sector Percentile

    17.6%
    EVGN market cap is higher than 17.6% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +33.8%
    EVGN shares outstanding is up +33.8% year-on-year

    Shares Outstanding 3-Year Change

    +111.48%
    EVGN shares outstanding is up +111.48% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.71
    EVGN beta is 0.71

    200-day SMA

    $1.23
    EVGN price is currently -10.26% below its 200-day simple moving average

    50-day SMA

    $1.14
    EVGN price is currently -3.22% below its 50-day simple moving average

    14-Day RSI

    53.24
    EVGN 14-day relative strength index is 53.24

    Volume

    3.12
    EVGN 30-day relative volume is 3.12

    ATR

    $0.07
    EVGN average true range is $0.07

    10-day Historical Volatility

    102.55%
    EVGN 10-day historical volatility is 102.55%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $8.51M
    EVGN annual revenue is $8.51 million

    Revenue Analysts Estimate

    $3.92M
    EVGN annual revenue is currently +117.39% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    +50.9%
    EVGN annual revenue is up +50.9% year-on-year

    Revenue Sector Percentile

    46.3%
    EVGN annual revenue is higher than 46.3% of companies in Healthcare sector

    EPS

    EPS

    -$2.89
    EVGN annual earnings per share is -$2.89

    EPS Analysts Estimate

    -$0.62
    EVGN annual earnings per share is currently -366.69% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +44.64%
    EVGN annual earnings per share is up +44.64% year-on-year

    EPS Sector Percentile

    30.79%
    EVGN annual earnings per share is higher than 30.79% of companies in Healthcare sector

    Profit

    Gross Profit

    $3.39M
    EVGN annual gross profit is $3.39 million

    Gross Margin

    39.81%
    EVGN annual gross profit margin is 39.81%

    Operating Profit

    -$21.73M
    EVGN annual operating income is -$21.73 million

    Operating Margin

    -315.56%
    EVGN annual operating profit margin is -315.56%

    Net Income

    -$18.05M
    EVGN annual net profit is -$18.05 million

    Net Margin

    -212.13%
    EVGN annual net profit margin is -212.13%

    Expenses

    Total Expenses

    $25.00M
    EVGN annual total expenses is $25.00 million

    Operating Expenses

    $25.12M
    EVGN annual total operating expenses is $25.12 million

    Cost Of Goods Sold

    $5.12M
    EVGN annual cost of goods sold is $5.12 million

    Selling, General & Administrative Expenses

    $0.00
    EVGN annual SG&A is $0.00

    Depreciation & Amortization

    $2.50M
    EVGN annual D&A is $2.50 million

    Interest Expense

    $0.00
    EVGN annual interest expense is $0.00

    Income Tax

    $9000.00
    EVGN annual income tax is $9000.00

    EBIT & EBITDA

    EBIT

    -$21.73M
    EVGN annual earnings before interest & taxes is -$21.73 million

    EBITDA

    -$19.23M
    EVGN annual EBITDA is -$19.23 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $39.86M
    EVGN annual total assets is $39.86 million

    Non Current Assets

    $18.27M
    EVGN annual long term assets is $18.27 million

    Current Assets

    $20.29M
    EVGN annual total current assets is $20.29 million

    Cash and Cash Equivalents

    $15.31M
    EVGN annual cash & cash equivalents is $15.31 million

    Accounts Receivable

    $1.09M
    EVGN annual accounts receivable is $1.09 million

    Inventory

    $3.18M
    EVGN annual inventory is $3.18 million

    Liabilities

    Total Liabilities

    $20.70M
    EVGN annual total liabilities is $20.70 million

    Long Term Liabilities

    $2.00M
    EVGN annual total long term liabilities is $2.00 million

    Current Liabilities

    $18.70M
    EVGN annual current liabilities is $18.70 million

    Accounts Payable

    $1.23M
    EVGN annual accounts payable is $1.23 million

    Debt

    Total Debt

    $2.50M
    EVGN annual total debt is $2.50 million

    Total Debt 1-Year Change

    +119.95%
    EVGN annual total debt is up +119.95% year-on-year

    Long Term Debt

    $1.91M
    EVGN annual long term debt is $1.91 million

    Short Term Debt

    $589.00K
    EVGN annual short term debt is $589.00 thousand

    Equity & Capital

    Shareholders Equity

    -$1.45M
    EVGN annual stockholders equity is -$1.45 million

    Book Value

    -$1.45M
    EVGN annual book value is -$1.45 million

    Retained Earnings

    -$274.07M
    EVGN annual retained earnings is -$274.07 million

    Working Capital

    $1.59M
    EVGN annual working capital is $1.59 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$19.70M
    EVGN annual cash from operations is -$19.70 million

    Cash From Operations 1-Year Change

    +8.7%
    EVGN annual cash from operations is up +8.7% year-on-year

    Cash From Investing

    $9.62M
    EVGN annual cash from investing is $9.62 million

    Cash From Investing 1-Year Change

    +312.03%
    EVGN annual cash from investing is up +312.03% year-on-year

    Cash From Financing

    $4.66M
    EVGN annual cash from financing is $4.66 million

    Cash From Financing 1-Year Change

    -74.35%
    EVGN annual cash from financing is down -74.35% year-on-year

    CAPEX

    CAPEX

    $626.00K
    EVGN annual capital expenditures is $626.00 thousand

    CAPEX 1-Year Change

    -20.25%
    EVGN annual capital expenditures is down -20.25% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$20.33M
    EVGN annual free cash flow is -$20.33 million

    Free Cash Flow 1-Year Change

    +9.1%
    EVGN annual free cash flow is up +9.1% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    39.81%
    EVGN annual gross profit margin is 39.81%

    Operating Margin

    -315.56%
    EVGN annual operating profit margin is -315.56%

    Net Margin

    -212.13%
    EVGN annual net profit margin is -212.13%

    ROA & ROE

    ROA

    -39.69%
    EVGN annual return on assets is -39.69%

    ROE

    -82.96%
    EVGN annual return on equity is -82.96%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    EVGN price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    EVGN price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    8.40
    EVGN price to book ratio is 8.40

    PB Ratio Sector Percentile

    85.7%
    EVGN price to book ratio is higher than 85.7% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    1.83
    EVGN price to sales ratio is 1.83

    PS Ratio Sector Percentile

    33.83%
    EVGN price to sales ratio is higher than 33.83% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    -$3.85M
    EVGN enterprise value is -$3.85 million

    Enterprise Value Sector Percentile

    7.2%
    EVGN enterprise value is higher than 7.2% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.30
    EVGN EV/EBITDA is 0.30

    EV/EBITDA Sector Percentile

    66.7%
    EVGN EV/EBITDA is higher than 66.7% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    1.09
    EVGN annual current ratio is 1.09

    Quick Ratio

    0.92
    EVGN annual quick ratio is 0.92

    Leverage

    Debt To Equity

    -1.73
    EVGN annual debt to equity ratio is -1.73

    Interest Coverage Ratio

    -
    EVGN annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    1
    EVGN piotroski f-score is 1

    Altman Z-Score

    -10.89
    EVGN altman z-score is -10.89

    Analyst ratings

    Recent major analysts updates

    May 22, 25 Lake Street
    Buy
    Aug 23, 24 Lake Street
    Buy
    Oct 2, 23 Alliance Global Partners
    Buy
    Aug 18, 23 Lake Street
    Buy
    Jul 21, 23 Roth MKM
    Buy
    May 2, 23 Lake Street
    Buy
    Sep 12, 22 Aegis Capital
    Buy
    Sep 2, 22 Roth MKM
    Buy
    Oct 8, 21 Roth Capital
    Buy
    Jul 29, 21 Aegis Capital
    Buy

    Institutional Ownership

    Screeners with EVGN included

    Growing Shares Outstanding
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biggest stock gainers today
    Biotech Companies
    • What is the ticker symbol for Evogene Ltd.?
    • Does Evogene Ltd. pay dividends?
    • What sector is Evogene Ltd. in?
    • What industry is Evogene Ltd. in?
    • What country is Evogene Ltd. based in?
    • When did Evogene Ltd. go public?
    • Is Evogene Ltd. in the S&P 500?
    • Is Evogene Ltd. in the NASDAQ 100?
    • Is Evogene Ltd. in the Dow Jones?
    • When was Evogene Ltd.'s last earnings report?
    • When does Evogene Ltd. report earnings?

    What is the ticker symbol for Evogene Ltd.?

    The ticker symbol for Evogene Ltd. is NASDAQ:EVGN

    Does Evogene Ltd. pay dividends?

    No, Evogene Ltd. does not pay dividends

    What sector is Evogene Ltd. in?

    Evogene Ltd. is in the Healthcare sector

    What industry is Evogene Ltd. in?

    Evogene Ltd. is in the Biotechnology industry

    What country is Evogene Ltd. based in?

    Evogene Ltd. is headquartered in Israel

    When did Evogene Ltd. go public?

    Evogene Ltd.'s initial public offering (IPO) was on October 15, 2010

    Is Evogene Ltd. in the S&P 500?

    No, Evogene Ltd. is not included in the S&P 500 index

    Is Evogene Ltd. in the NASDAQ 100?

    No, Evogene Ltd. is not included in the NASDAQ 100 index

    Is Evogene Ltd. in the Dow Jones?

    No, Evogene Ltd. is not included in the Dow Jones index

    When was Evogene Ltd.'s last earnings report?

    Evogene Ltd.'s most recent earnings report was on November 20, 2025

    When does Evogene Ltd. report earnings?

    The next expected earnings date for Evogene Ltd. is March 5, 2026
    On this page